会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 66. 发明公开
    • 신규한 히알루론산 기반 하이드로겔 및 이의 용도
    • 基于羟丙酸的新型氢化物及其用途
    • KR1020140090287A
    • 2014-07-17
    • KR1020120145758
    • 2012-12-13
    • 포항공과대학교 산학협력단주식회사 제넥신
    • 성영철한세광김기문김수진염준석정현태서유석진현탁
    • A61K9/06A61K31/728
    • A61K31/728A61K9/06A61K31/203A61K31/573
    • The present invention relates to hyaluronic acid-based hydrogel including a cell differentiating agent or a cell activity inducing material and produced using cucurbituril and polyamine, a cell treatment-assisting composition including the hydrogel, a cell treating composition including the hydrogel including a cell differentiating agent or a cell activity inducing material and mesenchymal stem cells, and a cell treatment-assisting composition including the hyaluronic acid-based hydrogel produced using cucurbituril and polyamine. Another purpose of the present invention relates to a cell treatment composition including the hydrogel and mesenchymal stem cells. The hyaluronic acid-based hydrogel provided in the present invention plays a role as a supplementary material for supporting stem cells which expresses a treatment material used as a cell treatment agent so as to promote the secretion of the treatment material and increase cell survival rates, so that the treatment effects of the cell treatment agent can be maximized. Accordingly, the hyaluronic acid-based hydrogel can be widely used to develop a cell treatment agent which exhibits improved effects.
    • 本发明涉及包含细胞分化剂或细胞活性诱导材料并使用葫芦巴和多胺制备的透明质酸系水凝胶,包含该水凝胶的细胞治疗辅助组合物,包含水凝胶的细胞处理组合物,其包含细胞分化剂 或细胞活性诱导材料和间充质干细胞,以及包含使用葫芦巴和多胺制备的透明质酸类水凝胶的细胞治疗辅助组合物。 本发明的另一个目的涉及包含水凝胶和间充质干细胞的细胞处理组合物。 本发明中提供的透明质酸水凝胶作为支持干细胞的辅助材料起作用,其表达用作细胞处理剂的处理材料,以促进处理材料的分泌并增加细胞存活率,因此 可以使细胞处理剂的处理效果最大化。 因此,透明质酸系水凝胶可广泛用于开发显示改善效果的细胞处理剂。
    • 67. 发明公开
    • 감응성 고분자 캡슐 및 그 제조방법
    • 反应性聚合物胶囊及其制备方法
    • KR1020110018111A
    • 2011-02-23
    • KR1020090075739
    • 2009-08-17
    • 포항공과대학교 산학협력단
    • 김기문이지영김동우김은주정현태
    • C08G61/12C08L65/00C08J3/12A61K47/34
    • C08J3/12A61K9/5138C08J2300/00C08J2365/00C08L65/00Y10T428/2982
    • PURPOSE: Responsive polymer capsules are provided to enable degradation within cells not but within blood and to effectively deliver drug within cytoplasm by employing pharmacologically active agents and/or targeted materials within capsules. CONSTITUTION: Polymer capsules are obtained by polymerizing a compound of chemical formula 1, or the compound of chemical formula 1 and a compound of chemical formula 2. The polymer capsules further include targeted compounds encapsulated in inner void of a cucurbituril ring and/or pharmacologically active agents sealed within the polymer capsules. The pharmacologically active agent is selected from the group consisting of hydrocortisone, prednisolone, spironolactone, testosterone, megestrol acetate, danazol, progesterone, indomethacin, amphotericin B and combinations thereof.
    • 目的:提供响应性聚合物胶囊,以在细胞内但不在血液内降解,并通过在胶囊内采用药理活性剂和/或靶向物质,有效地将药物递送至细胞质内。 构成:聚合物胶囊通过聚合化学式1的化合物或化学式1的化合物和化学式2的化合物而获得。聚合物胶囊还包括封装在葫芦巴环的内部空隙中和/或药理活性的靶向化合​​物 密封在聚合物胶囊内的试剂。 药理活性剂选自氢化可的松,泼尼松龙,螺内酯,睾酮,醋酸甲地孕酮,达那唑,孕酮,吲哚美辛,两性霉素B及其组合。